AKT1 and type 2 diabetes mellitus: In addition, dramatic decreases in the levels and activities of the insulin/phosphoinositide 3-kinase/protein kinase B (insulin–PI3K–AKT) signaling pathway in AD and T2DM subjects were reported [141].